GlassScriptPhysician profile
Joel P Jacobson
NPI 1346448859
$5,034.58
in general payments reported to CMS, 2019-2025
18 companies · $1,240 in 2025
The $1,240 reported for 2025 was more than what 83% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $369 · 2020: $191 · 2021: $50.68 · 2022: $161 · 2023: $985 · 2024: $2,037 · 2025: $1,240.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,262.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,262.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,838.62 | 2023-2025 | Inspire |
| Genzyme Corporation | $855.09 | 2023-2025 | |
| Glaxosmithkline, LLC. | $839.85 | 2022-2025 | Nucala |
| Stryker Corporation | $464.86 | 2019-2024 | Focess Hd Wireless Camera, Focess |
| Medtronic, INC. | $288.13 | 2022-2025 | Propel, Stealthstation S8 Platform, Nim Vital |
| Cochlear Americas | $139.82 | 2024 | Osia Osi300 Implant, Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode |
| Smith+Nephew, INC. | $123.30 | 2019-2025 | Stravix, Tula, Grafix Pl |
| Regeneron Healthcare Solutions, INC. | $93.03 | 2019-2024 | Dupixent |
| Cook Medical LLC | $80.97 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $55.15 | 2023-2024 | Austedo Xr, Ajovy |
| Kls-Martin L.P. | $46.07 | 2024 | |
| Optinose US, INC. | $38.89 | 2019-2024 | |
| Abbvie INC. | $37.01 | 2024 | |
| Medtronic USA, INC. | $33.61 | 2019-2020 | |
| Ethicon US, LLC | $32.68 | 2025 | Smartablatetm System Rf Generator, Harmonic |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intersect Ent, INC. | $27.55 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $24.39 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $15.56 | 2025 | Tezspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joel Jacobson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.